Song, Moo-Kon <br/><br/>
High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era.  [electronic resource] 

 -  Leukemia research  Mar 2016 
 - 1-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2016.01.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Area Under Curve<br/>Bone Marrow--pathology<br/>Cyclophosphamide--therapeutic use<br/>Disease-Free Survival<br/>Doxorubicin--therapeutic use<br/>Female<br/>Humans<br/>Image Interpretation, Computer-Assisted<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--metabolism<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Positron-Emission Tomography<br/>Prednisone--therapeutic use<br/>Prognosis<br/>Proportional Hazards Models<br/>ROC Curve<br/>Rituximab--therapeutic use<br/>Tomography, X-Ray Computed<br/>Tumor Burden<br/>Vincristine--therapeutic use